openPR Logo
Press release

Deadline on September 26th coming up in Lawsuit for Investors in Enochian Biosciences, Inc. (NASDAQ: ENOB)

09-20-2022 02:08 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A Deadline is coming up on September 26, 2022 in the lawsuit for certain investors in Enochian Biosciences, Inc. (NASDAQ: ENOB).

A Deadline is coming up on September 26, 2022 in the lawsuit for certain investors in Enochian Biosciences, Inc. (NASDAQ: ENOB).

A deadline is coming up on September 26, 2022 in the lawsuit filed for certain investors of Enochian Biosciences, Inc. (NASDAQ: ENOB) over alleged securities laws violations by Enochian Biosciences, Inc.

Investors who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and there are strict and short deadlines running. Deadline: September 26, 2022. NASDAQ: ENOB stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Central District of California the plaintiff alleges on behalf of purchasers of Enochian Biosciences, Inc. (NASDAQ: ENOB) common shares between September 24, 2020 and May 31, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between September 24, 2020 and May 31, 2022, the Defendants made false and/or misleading statements and/or failed to disclose thatGumrukcu was not a licensed doctor and had no verifiable degrees beyond high school, that accordingly, the scientific and technological underpinnings of Enochian's product pipeline, purportedly invented by Gumrukcu, were dubious at best, that accordingly, the Defendants had significantly overstated the commercial prospects for the Company's product pipeline, that Enochian's senior leadership knew Gumrukcu had a criminal history that included fraud, that accordingly, Enochian's reliance on Gumrukcu, and its consulting and licensing agreements with G-Tech and SRI, subjected the Company to a heightened risk of reputational and financial harm, as well as threatened the integrity of the Company's scientific findings, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Enochian Biosciences, Inc. (NASDAQ: ENOB) have certain options and should contact the Shareholders Foundation.

Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Deadline on September 26th coming up in Lawsuit for Investors in Enochian Biosciences, Inc. (NASDAQ: ENOB) here

News-ID: 2740472 • Views: 232

More Releases from Shareholders Foundation

Investigation announced for Investors who lost Money with their shares in Roblox …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Roblox Corporation. Investors who purchased shares of Roblox Corporation (NYSE: RBLX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Roblox directors breached their fiduciary duties and caused damage to the company and its shareholders. San Mateo, CA based Roblox Corporation develops
Investigation announced for Investors in Waterdrop Inc. (NYSE: WDH) over possibl …
An investigation was announced over potential securities laws violations by Waterdrop Inc. in connection with certain financial statements. Investors who purchased shares of Waterdrop Inc. (NYSE: WDH), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by Waterdrop Inc. (NYSE: WDH regarding its business, its prospects and its operations were materially
Sinovac Biotech Ltd. (formerly NASDAQ: SVA) Investor Notice: Deadline in Lawsuit …
A deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) over alleged securities laws violations by Sinovac Biotech Ltd. Investors who purchased shares of Sinovac Biotech Ltd. (formerly NASDAQ: SVA) have certain options and there are strict and short deadlines running. Deadline: October 17, 2022. Sinovac Biotech Ltd. (formerly NASDAQ: SVA) stockholders should contact the Shareholders Foundation at
Investigation announced for Investors in Anaplan, Inc. (NYSE: PLAN) over potenti …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Anaplan, Inc. Investors who are current long term investors in Anaplan, Inc. (NYSE: PLAN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: PLAN stocks follows a lawsuit filed against Anaplan, Inc. over

All 5 Releases